CD274 and neoplasm: Irinotecan treatment resulted in upregulated PD-L1 expression on tumor cells and on tumor-infiltrating dendritic cells and macrophages on Day 4, but by Day 8 PD-L1 expression was upregulated only on tumor cells (Figure 5B).